Skip to main content

Table 2 Serum levels of lipids, PCSK9, and atherogenic lipoprotein

From: Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease

Total cholesterol (mg/dl)

202 ± 34

LDL cholesterol (mg/dl)

129 ± 31

Triglycerides (mg/dl)

114 (36–573)

HDL cholesterol (mg/dl)

47 ± 11

Apolipoprotein A1 (mg/dl)

118 ± 20

Apolipoprotein B (mg/dl)

103 ± 24

Hetero-dimer PCSK9 (ng/ml)

145 ± 60

Furin-cleaved PCSK9 (ng/ml)

47 ± 32

Lipoprotein(a) (mg/dl)

16 (1–47)

Small, dense LDL (mg/dl)

25.8 ± 13.9

Oxidized LDL (U/ml)

11.8 ± 8.5

  1. Data are expressed as means ± SD or median (range)
  2. LDL low-density lipoprotein, HDL high-density lipoprotein, PCSK9 proprotein convertase subtilisin/kexin type 9